BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29408534)

  • 1. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.
    El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E
    J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism.
    Hangge PT; Dream S; Yen TWF; Doffek K; Stachowiak SM; Shaker J; Evans DB; Wang TS
    Ann Surg Oncol; 2024 Jun; 31(6):3964-3971. PubMed ID: 38459417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism.
    Starker LF; Akerström T; Long WD; Delgado-Verdugo A; Donovan P; Udelsman R; Lifton RP; Carling T
    Horm Cancer; 2012 Apr; 3(1-2):44-51. PubMed ID: 22187299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
    Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
    Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
    Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
    Park HS; Lee YH; Hong N; Won D; Rhee Y
    Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
    El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
    Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
    Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
    Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predicting the presence of
    Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
    Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRPT2- (CDC73) RELATED HEREDITARY HYPERPARATHYROIDISM: A CASE SERIES FROM WESTERN INDIA.
    Khadilkar KS; Budyal SR; Kasliwal R; Lila AR; Bandgar T; Shah NS
    Endocr Pract; 2015 Sep; 21(9):1010-6. PubMed ID: 26121439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Hyperparathyroidism in Young Adult Patients.
    Gasior J; Kelz RR; Karakousis GC; Fraker DL; Wachtel H
    Ann Surg Oncol; 2023 Jul; 30(7):4156-4164. PubMed ID: 36930370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.
    Romero Arenas MA; Morris LF; Rich TA; Cote GJ; Grubbs EG; Waguespack SG; Perrier ND
    J Pediatr Surg; 2014 Apr; 49(4):546-50. PubMed ID: 24726110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
    Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
    Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
    Trinh G; Rettig E; Noureldine SI; Russell JO; Agrawal N; Mathur A; Prescott JD; Zeiger MA; Tufano RP
    Otolaryngol Head Neck Surg; 2018 Oct; 159(4):630-637. PubMed ID: 30105919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.